Lv41
680 积分 2024-07-09 加入
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
5小时前
已完结
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
12天前
已完结
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
12天前
已完结
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
13天前
已完结
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention
14天前
已完结
Mylotarg: Revisiting Its Clinical Potential Post-Withdrawal
26天前
已完结
Regulatory Considerations
26天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
26天前
已完结
Exploring the next generation of antibody–drug conjugates
26天前
已完结
Abstract 6304: Preclinical development of a next generation antibody drug conjugate (ADC) targeting B7-H3 for treatment of solid tumors
1个月前
已关闭
皖公网安备34019202002308
